The result of research at Bonn University is a new bacterial compound that can inhibit the influenza virus.   

To create new ways of treating the influenza virus, the researchers wanted to exploit the process of multiplying infected host cells using the molecular repertoire. A team of scientists from the Institute of Cardiovascular Immunology at the University Hospital Bonn, led by Professor Hiroki Kato, has discovered a new bacterial compound that can block the ability of the virus to reproduce by inhibiting the function of the enzyme methyltransferase MTr1.